155 related articles for article (PubMed ID: 32855443)
1. Haploidentical stem cell transplantation with post-transplant cyclophosphamide for osteopetrosis and other nonmalignant diseases.
Even-Or E; NaserEddin A; Dinur Schejter Y; Shadur B; Zaidman I; Stepensky P
Bone Marrow Transplant; 2021 Feb; 56(2):434-441. PubMed ID: 32855443
[TBL] [Abstract][Full Text] [Related]
2. Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant Disorders.
Klein OR; Chen AR; Gamper C; Loeb D; Zambidis E; Llosa N; Huo J; Dezern AE; Steppan D; Robey N; Holuba MJ; Cooke KR; Symons HJ
Biol Blood Marrow Transplant; 2016 May; 22(5):895-901. PubMed ID: 26860634
[TBL] [Abstract][Full Text] [Related]
3. Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.
Fernandes JF; Bonfim C; Kerbauy FR; Rodrigues M; Esteves I; Silva NH; Azambuja AP; Mantovani LF; Kutner JM; Loth G; Kuwahara CC; Bueno C; Kondo AT; Ribeiro AAF; Kok F; Hamerschlak N
Bone Marrow Transplant; 2018 Apr; 53(4):392-399. PubMed ID: 29330393
[TBL] [Abstract][Full Text] [Related]
4. Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide in Wiskott-Aldrich Syndrome With Myeloablative Conditioning.
Sharma A; Rastogi N; Kapoor R; Chatterjee G; Yadav SP
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e230-e233. PubMed ID: 32459721
[TBL] [Abstract][Full Text] [Related]
5. Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide for Hemophagocytic Lymphohistiocytosis.
Kohli S; Rastogi N; Nivargi S; Thakkar D; Katewa S; Yadav SP
J Pediatr Hematol Oncol; 2019 Apr; 41(3):e158-e160. PubMed ID: 30044345
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune Cytopenias Post Hematopoietic Stem Cell Transplantation in Pediatric Patients With Osteopetrosis and Other Nonmalignant Diseases.
Even-Or E; Schejter YD; NaserEddin A; Zaidman I; Shadur B; Stepensky P
Front Immunol; 2022; 13():879994. PubMed ID: 35693771
[TBL] [Abstract][Full Text] [Related]
7. Haploidentical bone marrow transplantation in a pediatric patient with Wiskott-Aldrich syndrome. A case report.
Pury S; López Orozco M; Pichichero G; Sasia LV; Morell D; Álvarez MS; Basquiera AL; Mas ME; Salvucci K
Arch Argent Pediatr; 2024 Feb; 122(1):e202310061. PubMed ID: 37471507
[TBL] [Abstract][Full Text] [Related]
8. Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide/Bendamustine in Pediatric and Young Adult Patients with Hematologic Malignancies.
Katsanis E; Sapp LN; Varner N; Koza S; Stea B; Zeng Y
Biol Blood Marrow Transplant; 2018 Oct; 24(10):2034-2039. PubMed ID: 29908231
[TBL] [Abstract][Full Text] [Related]
9. Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Primary Immunodeficiencies and Inherited Disorders in Children.
Neven B; Diana JS; Castelle M; Magnani A; Rosain J; Touzot F; Moreira B; Fremond ML; Briand C; Bendavid M; Levy R; Morelle G; Vincent M; Magrin E; Bourget P; Chatenoud L; Picard C; Fischer A; Moshous D; Blanche S
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1363-1373. PubMed ID: 30876929
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
11. [Transplantation of highly purified CD34+ hematologic peripheral stem cells from haploidentical related donors in the treatment of children with non-malignant diseases].
Starý J; Sedlácek P; Vodvárková S; Poloucková A; Formánková R; Gasová Z; Marinov I
Cas Lek Cesk; 2002 Mar; 141(6):176-81. PubMed ID: 11977835
[TBL] [Abstract][Full Text] [Related]
12. Non-total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide in hematopoietic stem cell transplantation for malignant infantile osteopetrosis.
Behfar M; Dehghani SS; Hosseini AS; Jalali A; Hamidieh AA; Ghavamzadeh A
Pediatr Transplant; 2015 Jun; 19(4):422-7. PubMed ID: 25879376
[TBL] [Abstract][Full Text] [Related]
13. Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT.
Ruggeri A; Labopin M; Bacigalupo A; Afanasyev B; Cornelissen JJ; Elmaagacli A; Itälä-Remes M; Blaise D; Meijer E; Koc Y; Milpied N; Schouten HC; Kroeger N; Mohty M; Nagler A
J Hematol Oncol; 2018 Mar; 11(1):40. PubMed ID: 29544522
[TBL] [Abstract][Full Text] [Related]
14. Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide.
Oostenbrink LVE; Pool ES; Jol-van der Zijde CM; Jansen-Hoogendijk AM; Vervat C; van Halteren AGS; Bredius RGM; Smiers FJW; van Tol MJD; Schilham MW; Lankester AC; Mohseny AB
Bone Marrow Transplant; 2021 Sep; 56(9):2203-2211. PubMed ID: 33941871
[TBL] [Abstract][Full Text] [Related]
15. Haploidentical transplantation in pediatric non-malignant diseases: A retrospective analysis on behalf of the Spanish Group for Hematopoietic Transplantation (GETH).
Torres Canizales J; Ferreras C; Pascual A; Alonso L; Regueiro A; Plaza M; Pérez Hurtado JM; Benito A; Couselo JM; Fuster JL; Díaz-Almirón M; Bueno D; Mozo Y; Gómez López A; Vicario JL; Balas A; Sisinni L; Díaz de Heredia C; Pérez-Martínez A
Eur J Haematol; 2021 Feb; 106(2):196-204. PubMed ID: 33084101
[TBL] [Abstract][Full Text] [Related]
16. Prospective Study of Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide and Antithymocyte Globulin from HLA-Mismatched Related Donors for Nonmalignant Diseases.
Osumi T; Yoshimura S; Sako M; Uchiyama T; Ishikawa T; Kawai T; Inoue E; Takimoto T; Takeuchi I; Yamada M; Sakamoto K; Yoshida K; Kimura Y; Matsukawa Y; Matsumoto K; Imadome KI; Arai K; Deguchi T; Imai K; Yuza Y; Matsumoto K; Onodera M; Kanegane H; Tomizawa D; Kato M
Biol Blood Marrow Transplant; 2020 Nov; 26(11):e286-e291. PubMed ID: 32798657
[TBL] [Abstract][Full Text] [Related]
17. Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Children and Adolescents with Fanconi Anemia.
Bonfim C; Ribeiro L; Nichele S; Loth G; Bitencourt M; Koliski A; Kuwahara C; Fabro AL; Pereira NF; Pilonetto D; Thakar M; Kiem HP; Page K; Fuchs EJ; Eapen M; Pasquini R
Biol Blood Marrow Transplant; 2017 Feb; 23(2):310-317. PubMed ID: 27832981
[TBL] [Abstract][Full Text] [Related]
18. Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.
Muñiz P; Andrés-Zayas C; Carbonell D; Chicano M; Bailén R; Oarbeascoa G; Suárez-González J; Gómez Centurión I; Dorado N; Gallardo D; Anguita J; Kwon M; Díez-Martín JL; Martínez-Laperche C; Buño I
Front Immunol; 2022; 13():1002959. PubMed ID: 36211438
[TBL] [Abstract][Full Text] [Related]
19. Haploidentical transplant in patients with myelodysplastic syndrome.
Robin M; Porcher R; Ciceri F; van Lint MT; Santarone S; Ehninger G; Blaise D; Güllbas Z; Gonzáles Muñiz S; Michallet M; Velardi A; Koster L; Maertens J; Sierra J; Selleslag D; Radujkovic A; Díez-Martin JL; Kanz L; Arroyo CH; Niederwieser D; Huang H; McDonald A; de Witte T; Koc Y; Kröger N
Blood Adv; 2017 Oct; 1(22):1876-1883. PubMed ID: 29296834
[TBL] [Abstract][Full Text] [Related]
20. [Application of low dose of fludarabine and cyclophosphamide combined with donor NK Cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice].
Yu JP; Cao S; Xin N; An XM; Qi J; Ren XB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1013-8. PubMed ID: 17956681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
